Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases

Rehab H Werida1, Ayman Omran2, Noha M El-Khodary1

  • 1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.

Insights

Elevated homocysteine and sortilin levels are key risk factors for coronary artery disease (CAD) in Egyptian patients. This study highlights their association with CAD, emphasizing their importance in cardiac risk assessment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Research

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Understanding CAD risk factors is crucial for effective prevention and treatment strategies.

Purpose of the Study:

  • To investigate the association between coronary artery disease (CAD) and the levels of homocysteine and sortilin in an Egyptian population.
  • To identify potential biomarkers for CAD risk in this demographic.

Main Methods:

  • A cohort of 45 Egyptian patients diagnosed with CAD via coronary CT angiography was compared to 42 healthy controls.
  • Plasma levels of homocysteine and sortilin were quantified using a commercial ELISA kit.

Main Results:

  • Patients with CAD exhibited significantly higher levels of homocysteine and sortilin compared to controls.
  • CAD patients also showed dyslipidemia, with higher total cholesterol, LDL, and triglycerides, and lower HDL.
  • Sortilin levels demonstrated positive correlations with homocysteine, lipids, troponin I, Gensini score, and hs-CRP.

Conclusions:

  • Elevated homocysteine and sortilin are identified as significant risk factors for coronary artery disease (CAD) in Egyptian patients.
  • These findings suggest that homocysteine and sortilin may serve as important biomarkers for CAD risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
262
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
413
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
498
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
46
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
83